392 filings
DEF 14A
PMCB
PharmaCyte Biotech Inc
Definitive proxy
27 Mar 24
4:06pm
ARS
2023 FY
PMCB
PharmaCyte Biotech Inc
27 Mar 24
Annual report to shareholders
4:05pm
10-Q
2024 Q3
PMCB
PharmaCyte Biotech Inc
Quarterly report
18 Mar 24
4:02pm
SC 13G
Ayrton Capital LLC
14 Feb 24
PharmaCyte Biotech / Ayrton Capital ownership change
3:38pm
SC 13G/A
PMCB
PharmaCyte Biotech Inc
6 Feb 24
PharmaCyte Biotech / INTRACOASTAL CAPITAL ownership change
9:56am
3
km63a1i m9du8iuhy
28 Nov 23
Initial statement of insider ownership
5:06pm
8-K
agzoa35sz6yq8o4ae
24 Nov 23
Departure of Directors or Certain Officers
4:00pm
4
rigko33
22 Nov 23
PharmaCyte Biotech / ROBERT WEINSTEIN ownership change
5:02pm
4
xnesxf9gcp
22 Nov 23
PharmaCyte Biotech / WAYNE REMELL WALKER ownership change
5:02pm
4
h8fhxddw
22 Nov 23
PharmaCyte Biotech / Carlos Trujillo ownership change
5:01pm
4
jnzbzcof
22 Nov 23
PharmaCyte Biotech / Joshua Silverman ownership change
5:01pm
4
4qb4ftmc1cnxksb
22 Nov 23
PharmaCyte Biotech / JONATHAN SCHECHTER ownership change
5:01pm
4
j40n2d5c 60
22 Nov 23
PharmaCyte Biotech / Michael M Abecassis ownership change
5:00pm
SC 13D
tdb6nzewyz
22 Nov 23
FEMASYS / PharmaCyte Biotech ownership change
4:00pm
8-K
u5e 277vxgm7k58t581e
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
tmcdq2na635mymg8lsu0
9 Nov 23
Changes in Registrant's Certifying Accountant
5:25pm
EFFECT
13dgjwp09b2y1qj2y
2 Oct 23
Notice of effectiveness
12:15am
CORRESP
tzlyngfjgxdk0r
27 Sep 23
Correspondence with SEC
12:00am